EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PP2A B55α inhibits epithelial-mesenchymal transition via regulation of Slug expression in non-small cell lung cancer

Deepika Singh, Zhaojun Qiu, Spehar M Jonathan, Pengyan Fa, Hannah Thomas, Chandra Bhushan Prasad, Shurui Cai, Jing J Wang, Chunhong Yan, Xiaoli Zhang, Monica Venere, Zaibo Li und 3 weitere

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Deepika Singh und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center and College of Medicine, Columbus, OH, United States. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Snail Family Transcription Factors, Carcinoma, Non-Small-Cell Lung, Protein Phosphatase 2. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PP2A B55α, encoded by PPP2R2A, acts as a regulatory subunit of the serine/threonine phosphatase PP2A. Despite a frequent loss of heterozygosity of PPP2R2A in cases of non-small cell lung cancer (NSCLC), research on PP2A B55α's functions remains limited and controversial. To investigate the biological roles of PP2A B55α, we conducted bulk RNA-sequencing to assess the impact of PPP2R2A knockdown using two shRNAs in a NSCLC cell line. Gene set enrichment analysis (GSEA) of the RNA-sequencing data revealed significant enrichment of the epithelial-mesenchymal transition (EMT) pathway, with SNAI2 (the gene encoding Slug) emerging as one of the top candidates. Our findings demonstrate that PP2A B55α suppresses EMT, as PPP2R2A deficiency through knockdown or homozygous or hemizygous depletion promotes EMT and metastatic behavior in NSCLC cells, as evidenced by changes in EMT biomarkers, invasion and migration abilities, as well as metastasis in a tail vein assay. Mechanistically, PP2A B55α inhibits EMT by downregulating SNAI2 expression via the GSK3β-β-catenin pathway. Importantly, PPP2R2A deficiency also slows cell proliferation by disrupting DNA replication, particularly in PPP2R2A-/- cells. Furthermore, PPP2R2A deficiency, especially PPP2R2A-/- cells, leads to an increase in the cancer stem cell population, which correlates with enhanced resistance to chemotherapy. Overall, the decrease in PP2A B55α levels due to hemizygous/homozygous depletion heightens EMT and the metastatic or stemness/drug resistance potential of NSCLC cells despite their proliferation disadvantage. Our study highlights the significance of PP2A B55α in EMT and metastasis and suggests that targeting EMT/stemness could be a potential therapeutic strategy for treating PPP2R2A-deficient NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionSnail Family Transcription FactorsCarcinoma, Non-Small-Cell LungProtein Phosphatase 2Lung NeoplasmsGene Expression Regulation, NeoplasticHumansAnimalsCell MovementCell Line, TumorGlycogen Synthase Kinase 3 betaA549 CellsMiceNeoplasm Invasiveness

Substanzen

Snail Family Transcription FactorsProtein Phosphatase 2SNAI1 protein, humanPPP2R2A protein, humanSNAI2 protein, humanGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • The Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center and College of Medicine, Columbus, OH, United States.
  • The Ohio State University, Columbus, OH, United States.
  • The Department of Cancer Biology and Genetics, The Ohio State University Comprehensive Cancer Center and College of Medicine, Columbus, OH, United States.
  • Georgia Cancer Center, Augusta University, Augusta, GA, United States.
  • Center for Biostatistics, The Ohio State University, United States; Department of Biomedical Informatics, College of Medicine, The Ohio State University, United States.
  • The Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center and College of Medicine, Columbus, OH, United States; The James Comprehensive Cancer Center, Pelotonia Institute for Immuno-Onc…

Förderung

  • NCI NIH HHS

Zitieren

APA

Singh, D., Qiu, Z., Jonathan, S. M., Fa, P., Thomas, H., Prasad, C. B., Cai, S., Wang, J. J., Yan, C., Zhang, X., Venere, M., Li, Z., Sizemore, S. T., Wang, Q. E., & Zhang, J. (2024). PP2A B55α inhibits epithelial-mesenchymal transition via regulation of Slug expression in non-small cell lung cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217110

Vancouver

Singh D, Qiu Z, Jonathan SM, Fa P, Thomas H, Prasad CB, et al. PP2A B55α inhibits epithelial-mesenchymal transition via regulation of Slug expression in non-small cell lung cancer. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217110

BibTeX
@article{Singh2024,
  author = {Singh, Deepika and Qiu, Zhaojun and Jonathan, Spehar M and Fa, Pengyan and Thomas, Hannah and Prasad, Chandra Bhushan and Cai, Shurui and Wang, Jing J and Yan, Chunhong and Zhang, Xiaoli and Venere, Monica and Li, Zaibo and Sizemore, Steven T and Wang, Qi-En and Zhang, Junran},
  title = {PP2A B55α inhibits epithelial-mesenchymal transition via regulation of Slug expression in non-small cell lung cancer},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217110}
}
Kostenlos starten →